Penn Engineers have developed a new way to use AI to solve inverse partial differential equations (PDEs), a particularly ...

ByteDance's drug unit showed an AI-designed IL-17 inhibitor at a Boston conference. The molecule targets interactions pharma called undruggable. Only trials will tell.